V. Appay, J. J. Zaunders, L. Papagno, J. Sutton, A. Jaramillo et al., Characterization of CD4+ CTLs Ex Vivo, The Journal of Immunology, vol.168, issue.11, pp.5954-5958, 2002.
DOI : 10.4049/jimmunol.168.11.5954

E. Aruga, K. Tanigawa, A. Aruga, H. Arai, J. W. Smith et al., CD95-Mediated Tumor Recognition by CD4+ Effector Cells in a Murine Mammary Model, Journal of Immunotherapy, vol.23, issue.2, pp.225-234, 2000.
DOI : 10.1097/00002371-200003000-00007

T. P. Baum, N. Pasqual, F. Thuderoz, V. Hierle, D. Chaume et al., IMGT/GeneInfo: enhancing V(D)J recombination database accessibility, Database issue), pp.32-51, 2004.
DOI : 10.1093/nar/gkh041

M. Bendandi, C. D. Gocke, C. B. Kobrin, F. A. Benko, L. A. Sternas et al., Complete molecular remissions induced by patient-specific vaccination plus granulocyte?monocyte colony-stimulating factor against lymphoma, Nature Medicine, vol.5, pp.1171-1177, 1999.

T. Bonnefoix and J. J. Sotto, The standard ??2 test used in limiting dilution assays is insufficient for estimating the goodness-of-fit to the single-hit Poisson model, Journal of Immunological Methods, vol.167, issue.1-2, pp.21-33, 1994.
DOI : 10.1016/0022-1759(94)90071-X

T. Bonnefoix, P. Bonnefoix, M. Callanan, P. Verdiel, and J. J. Sotto, Graphical Representation of a Generalized Linear Model-Based Statistical Test Estimating the Fit of the Single-Hit Poisson Model to Limiting Dilution Assays, The Journal of Immunology, vol.167, issue.10, pp.5725-5730, 2001.
DOI : 10.4049/jimmunol.167.10.5725

T. Bonnefoix, J. Q. Mi, P. Perron, M. Callanan, C. Semoun et al., Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4+ T cells in one case of splenic marginal zone B-cell lymphoma, Blood, vol.99, issue.1, pp.388-391, 2002.
DOI : 10.1182/blood.V99.1.388

L. Bouhdoud, P. Villain, A. Merzouki, M. Arella, and C. Couture, T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide, Journal of Virology, vol.74, issue.5, pp.2121-2130, 2000.
DOI : 10.1128/JVI.74.5.2121-2130.2000

E. Claret, V. Praloran, X. Zheng, T. Bonnefoix, M. F. Sotto et al., Accumulation of T-cell clones producing high levels of both granulocyte-macrophage and macrophage colony-stimulating factors (CSF-1) in lymph nodes involved by Hodgkin's disease, Leukemia, vol.6, pp.820-827, 1992.

M. E. Dudley, J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu et al., Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes, Science, vol.298, issue.5594, pp.850-854, 2002.
DOI : 10.1126/science.1076514

M. E. Dudley, J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian et al., Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma, Journal of Clinical Oncology, vol.23, issue.10, pp.2346-2357, 2005.
DOI : 10.1200/JCO.2005.00.240

M. Eray, V. Postila, J. Eeva, A. Ripatti, M. Karjalainen-lindsberg et al., Follicular Lymphoma Cell Lines, an In Vitro Model for Antigenic Selection and Cytokine-Mediated Growth Regulation of Germinal Centre B Cells, Scandinavian Journal of Immunology, vol.162, issue.6, pp.545-555, 2003.
DOI : 10.1146/annurev.immunol.16.1.293

M. T. Esser, D. M. Haverstick, C. L. Fuller, C. A. Gullo, and V. L. Braciale, Signaling Modulates Cytolytic T Lymphocyte Effector Functions, The Journal of Experimental Medicine, vol.156, issue.7, pp.1057-1067, 1998.
DOI : 10.1002/eji.1830260944

Z. Fehervari and S. Sakaguchi, CD4+ Tregs and immune control, Journal of Clinical Investigation, vol.114, issue.9, pp.1209-1217, 2004.
DOI : 10.1172/JCI200423395

S. Flynn and B. Stockinger, Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation, Blood, vol.101, issue.11, pp.4472-4478, 2003.
DOI : 10.1182/blood-2002-10-3030

E. Gilboa, The Makings of a Tumor Rejection Antigen, Immunity, vol.11, issue.3, pp.263-270, 1999.
DOI : 10.1016/S1074-7613(00)80101-6

E. Gilboa, Opinion: The promise of cancer vaccines, Nature Reviews Cancer, vol.4, issue.5, pp.401-411, 2004.
DOI : 10.1038/nrc1359

D. I. Godfrey, K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter, NKT cells: facts, functions and fallacies, Immunology Today, vol.21, issue.11, pp.573-583, 2000.
DOI : 10.1016/S0167-5699(00)01735-7

D. I. Godfrey, H. R. Macdonald, M. Kronenberg, M. J. Smyth, and L. Van-kaer, Opinion: NKT cells: what's in a name?, Nature Reviews Immunology, vol.11, issue.3, pp.231-237, 2004.
DOI : 10.1038/nri1309

A. N. Houghton, J. S. Gold, and N. E. Blachere, Immunity against cancer: lessons learned from melanoma, Current Opinion in Immunology, vol.13, issue.2, pp.134-140, 2001.
DOI : 10.1016/S0952-7915(00)00195-3

K. Hung, R. Hayashi, A. Lafond-walker, C. Lowenstein, D. Pardoll et al., T Cells in the Antitumor Immune Response, The Journal of Experimental Medicine, vol.156, issue.12, pp.2357-2368, 1998.
DOI : 10.1084/jem.179.2.447

S. T. Ju, H. Cui, D. J. Panka, R. Ettinger, and A. Marshak-rothstein, Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells., Proceedings of the National Academy of Sciences of the United States of America, pp.4185-4189, 1994.
DOI : 10.1073/pnas.91.10.4185

T. Kataoka, N. Shinohara, H. Takayama, K. Takaku, S. Kondo et al., Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-and Fas-based lytic pathways in cell-mediated cytotoxicity, Journal of Immunology, vol.156, pp.3678-3686, 1996.

H. T. Khong and N. P. Restifo, Natural selection of tumor variants in the generation of ???tumor escape??? phenotypes, Nature Immunology, vol.3, issue.11, pp.999-1005, 2002.
DOI : 10.1038/ni1102-999

A. Lajmanovich, M. Irisarri, J. P. Molens, M. A. Pasquier, J. J. Sotto et al., Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells, British Journal of Haematology, vol.94, issue.6, pp.746-753, 2004.
DOI : 10.1074/jbc.274.3.1646

M. P. Lefranc, IMGT, the international ImMunoGeneTics database(R), Nucleic Acids Research, vol.31, issue.1, pp.307-310, 2003.
DOI : 10.1093/nar/gkg085

J. H. Li, D. Rosen, D. Ronen, C. K. Behrens, P. H. Krammer et al., The regulation of CD95 ligand expression and function in CTL, Journal of Immunology, vol.161, pp.3943-3949, 1998.

K. U. Lundin, P. O. Hofgaard, H. Omholt, L. A. Munthe, A. Corthay et al., Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies, Blood, vol.102, issue.2, pp.605-612, 2003.
DOI : 10.1182/blood-2002-11-3381

I. Martin, T. Bonnefoix, C. Roucard, P. Perron, A. Lajmanovich et al., Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma: aborted activation and G1 blockade induced by cell-cell contact, European Journal of Immunology, vol.78, issue.10, pp.3188-3195, 1999.
DOI : 10.1002/(SICI)1521-4141(199910)29:10<3188::AID-IMMU3188>3.0.CO;2-D

S. Marusic-galesic, K. Udaka, and P. Walden, Increased number of cytotoxic T cells within CD4+8??? T cells in ??2-microglobulin, major histocompatibility complex class I-deficient mice, European Journal of Immunology, vol.10, issue.12, pp.3115-3119, 1993.
DOI : 10.1002/eji.1830231211

A. L. Marzo, B. F. Kinnear, R. A. Lake, J. J. Frelinger, E. J. Collins et al., Tumor-Specific CD4+ T Cells Have a Major "Post-Licensing" Role in CTL Mediated Anti-Tumor Immunity, The Journal of Immunology, vol.165, issue.11, pp.6047-6055, 2000.
DOI : 10.4049/jimmunol.165.11.6047

J. Mattes, M. Hulett, W. Xie, S. Hogan, M. E. Rothenberg et al., Immunotherapy of Cytotoxic T Cell???resistant Tumors by T Helper 2 Cells, The Journal of Experimental Medicine, vol.56, issue.3, pp.387-393, 2003.
DOI : 10.1056/NEJM199805283382206

E. P. Miskovsky, A. Y. Liu, W. Pavlat, R. Viveen, P. E. Stanhope et al., Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines, Journal of Immunology, vol.153, pp.2787-2799, 1994.

D. Mumberg, P. A. Monach, S. Wanderling, M. Philip, A. Y. Toledano et al., CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma, Proceedings of the National Academy of Sciences of the United States of America, pp.8633-8638, 1999.

K. Nagata, K. Tanaka, K. Ogawa, K. Kemmotsu, T. Imai et al., Selective expression of a novel surface molecule by human Th2 cells in vivo, Journal of Immunology, vol.162, pp.1278-1286, 1999.

S. Nikiforow, K. Bottomly, G. Miller, and C. Munz, Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation, Journal of Virology, vol.77, issue.22, pp.12088-12104, 2003.
DOI : 10.1128/JVI.77.22.12088-12104.2003

M. T. Ochoa, S. Stenger, P. A. Sieling, S. Thoma-uszynski, S. Sabet et al., T-cell release of granulysin contributes to host defense in leprosy, Nature Medicine, vol.7, issue.2, pp.174-179, 2001.
DOI : 10.1038/84620

H. Ohminami, M. Yasukawa, S. Kaneko, Y. Yakushijin, Y. Abe et al., Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide, Blood, vol.93, pp.925-935, 1999.

F. Ossendorp, R. E. Toes, R. Offringa, S. H. Van-der-burg, and C. J. Melief, Importance of CD4+ T helper cell responses in tumor immunity, Immunology Letters, vol.74, issue.1, pp.75-79, 2000.
DOI : 10.1016/S0165-2478(00)00252-2

D. M. Pardoll and S. L. Topalian, The role of CD4+ T cell responses in antitumor immunity, Current Opinion in Immunology, vol.10, issue.5, pp.588-594, 1998.
DOI : 10.1016/S0952-7915(98)80228-8

N. Pasqual, M. Gallagher, C. Aude-garcia, M. Loiodice, F. Thuderoz et al., Quantitative and Qualitative Changes in V-J ?? Rearrangements During Mouse Thymocytes Differentiation, The Journal of Experimental Medicine, vol.144, issue.9, pp.1163-1173, 2002.
DOI : 10.1016/0167-5699(92)90044-8

H. R. Pelham, Multiple targets for brefeldin A, Cell, vol.67, issue.3, pp.449-451, 1991.
DOI : 10.1016/0092-8674(91)90517-3

J. Plumas, L. Chaperot, M. C. Jacob, J. P. Molens, C. Giroux et al., Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80, ) in stimulation by tumor cells, pp.7-8, 1995.

J. Plumas, M. C. Jacob, L. Chaperot, J. P. Molens, J. J. Sotto et al., Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis, Blood, vol.91, pp.2875-2885, 1998.

I. Puisieux, J. Even, C. Pannetier, F. Jotereau, M. Favrot et al., Oligoclonality of tumor-infiltrating lymphocytes from human melanomas, Journal of Immunology, vol.153, pp.2807-2818, 1994.

Z. Qin and T. Blankenstein, CD4+ T Cell???Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFN?? Receptor Expression by Nonhematopoietic Cells, Immunity, vol.12, issue.6, pp.677-686, 2000.
DOI : 10.1016/S1074-7613(00)80218-6

J. C. Rathmell, M. P. Cooke, W. Y. Ho, J. Grein, S. E. Townsend et al., CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells, Nature, vol.376, issue.6536, pp.181-184, 1995.
DOI : 10.1038/376181a0

F. Sallusto, C. R. Mackay, and A. Lanzavecchia, The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses, Annual Review of Immunology, vol.18, issue.1, pp.593-620, 2000.
DOI : 10.1146/annurev.immunol.18.1.593

C. Schmaltz, O. Alpdogan, K. J. Horndasch, S. J. Muriglan, B. J. Kappel et al., Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect, Blood, vol.97, issue.9, pp.2886-2895, 2001.
DOI : 10.1182/blood.V97.9.2886

E. S. Schultz, B. Schuler-thurner, V. Stroobant, L. Jenne, T. G. Berger et al., Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy, The Journal of Immunology, vol.172, issue.2, pp.1304-1310, 2004.
DOI : 10.4049/jimmunol.172.2.1304

I. Shi, T. Bonnefoix, F. Heuze-le-vacon, M. C. Jacob, D. Leroux et al., Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas, British Journal of Haematology, vol.10, issue.4, pp.837-843, 1995.
DOI : 10.1084/jem.169.5.1557

Q. Sun, R. L. Burton, and K. G. Lucas, Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures, Blood, vol.99, issue.9, pp.3302-3309, 2002.
DOI : 10.1182/blood.V99.9.3302

I. Theodorou, C. Bigorgne, M. H. Delfau, C. Lahet, G. Cochet et al., VJ REARRANGEMENTS OF THE TCR?? LOCUS IN PERIPHERAL T-CELL LYMPHOMAS: ANALYSIS BY POLYMERASE CHAIN REACTION AND DENATURING GRADIENT GEL ELECTROPHORESIS, The Journal of Pathology, vol.316, issue.3, pp.303-310, 1996.
DOI : 10.1002/(SICI)1096-9896(199603)178:3<303::AID-PATH475>3.0.CO;2-I

D. T. Umetsu, L. Esserman, T. A. Donlon, R. H. Dekruyff, and R. Levy, Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones, Journal of Immunology, vol.144, pp.2550-2557, 1990.

I. Vigan, E. Jouvin-marche, V. Leroy, M. Pernollet, S. Tongiani-dashan et al., T lymphocytes infiltrating the liver during chronic hepatitis C infection express a broad range of T-cell receptor beta chain diversity, Journal of Hepatology, vol.38, issue.5, pp.651-659, 2003.
DOI : 10.1016/S0168-8278(03)00089-8

R. F. Wang, The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity, Trends in Immunology, vol.22, issue.5, pp.269-276, 2001.
DOI : 10.1016/S1471-4906(01)01896-8

S. Wang, Z. F. Boonman, H. C. Li, Y. He, M. J. Jager et al., Role of TRAIL and IFN-?? in CD4+ T Cell-Dependent Tumor Rejection in the Anterior Chamber of the Eye, The Journal of Immunology, vol.171, issue.6, pp.2789-2796, 2003.
DOI : 10.4049/jimmunol.171.6.2789

N. S. Williams and V. H. Engelhard, Identification of a population of CD4+ CTL that utilizes a perforin-rather than a Fas liganddependent cytotoxic mechanism, Journal of Immunology, vol.156, pp.153-159, 1996.

F. Yanai, E. Ishii, K. Kojima, A. Hasegawa, T. Azuma et al., Essential Roles of Perforin in Antigen-Specific Cytotoxicity Mediated by Human CD4+ T Lymphocytes: Analysis Using the Combination of Hereditary Perforin-Deficient Effector Cells and Fas-Deficient Target Cells, The Journal of Immunology, vol.170, issue.4, pp.2205-2213, 2003.
DOI : 10.4049/jimmunol.170.4.2205

Z. Z. Yang, A. J. Novak, M. J. Stenson, T. E. Witzig, and S. M. Ansell, Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma, Blood, vol.107, issue.9, pp.3639-3646, 2006.
DOI : 10.1182/blood-2005-08-3376

M. Yasukawa, Y. Yakushijin, H. Hasegawa, M. Miyake, Y. Hitsumoto et al., Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factorbeta ) in virus-specific CD4+ human cytotoxic T-cell clones, Blood, vol.81, pp.1527-1534, 1993.

C. Yee, J. A. Thompson, D. Byrd, S. R. Riddell, P. Roche et al., Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells, Proceedings of the National Academy of Sciences of the United States of America, pp.16168-16173, 2002.
DOI : 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0